Source: Asian Venture Capital Journal

RA Capital: RA Capital leads round for China's Connect Biopharma

Connect Biopharma, a drug developer based in China and the US, has raised $115 million in Series C funding led by RA Capital Management.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Peter Kolchinsky's photo - Managing Partner of RA Capital

Managing Partner

Peter Kolchinsky

CEO Approval Rating

68/100

RA Capital Management is a venture capital firm that invests in healthcare and life-sciences companies. Read more